{"id":"decadron-phosphate-injectable","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes (euphoria, irritability)"},{"rate":null,"effect":"Increased infection risk"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Osteoporosis (with chronic use)"},{"rate":null,"effect":"Adrenal suppression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone phosphate enters cells and binds to intracellular glucocorticoid receptors, which then translocate to the nucleus and modulate gene transcription. This leads to decreased production of pro-inflammatory cytokines, reduced immune cell activation and proliferation, and suppression of inflammatory mediators. The injectable phosphate ester formulation allows for rapid systemic delivery and is commonly used for acute inflammatory and immunological conditions.","oneSentence":"Dexamethasone phosphate is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:32:14.952Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and allergic disorders"},{"name":"Rheumatoid arthritis and other autoimmune conditions"},{"name":"Cerebral edema"},{"name":"Acute leukemia (supportive care)"},{"name":"Severe infections with systemic inflammation"}]},"trialDetails":[{"nctId":"NCT07494136","phase":"PHASE4","title":"Dose Dependent Steroid Injections","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-05","conditions":"Lumbar Radiculopathy, Sciatica, Back Pain With Radiation","enrollment":150},{"nctId":"NCT02773030","phase":"PHASE1, PHASE2","title":"A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celgene","startDate":"2016-10-14","conditions":"Multiple Myeloma","enrollment":466},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT05272826","phase":"PHASE2","title":"Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients","status":"RECRUITING","sponsor":"Canadian Myeloma Research Group","startDate":"2024-12-12","conditions":"Multiple Myeloma","enrollment":75},{"nctId":"NCT03661645","phase":"PHASE4","title":"Post-operative Methylprednisolone Taper Course for Orthopedic Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Emory University","startDate":"2018-09-07","conditions":"Orthopedic Surgeries","enrollment":500},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT04151667","phase":"PHASE2","title":"Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-11-22","conditions":"Multiple Myeloma","enrollment":33},{"nctId":"NCT06930690","phase":"PHASE1, PHASE2","title":"Dexamethasone for Ureteral STent Symptoms (DUSTS)","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-04","conditions":"Ureteral Stent-Related Symptom","enrollment":70},{"nctId":"NCT05023369","phase":"PHASE4","title":"This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time","status":"RECRUITING","sponsor":"Ente Ospedaliero Cantonale, Bellinzona","startDate":"2021-12-10","conditions":"Femoral Neck Fractures","enrollment":110},{"nctId":"NCT05257941","phase":"PHASE1, PHASE2","title":"ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery","status":"TERMINATED","sponsor":"Indiana University","startDate":"2022-01-27","conditions":"Surgery","enrollment":116},{"nctId":"NCT03909412","phase":"PHASE1","title":"Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2019-10-08","conditions":"Multiple Myeloma","enrollment":18},{"nctId":"NCT07101445","phase":"PHASE4","title":"Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-09-24","conditions":"Multiple Myeloma","enrollment":94},{"nctId":"NCT04414475","phase":"PHASE2","title":"A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.","status":"RECRUITING","sponsor":"Karyopharm Therapeutics Inc","startDate":"2020-07-01","conditions":"Multiple Myeloma, Refractory","enrollment":127},{"nctId":"NCT07216820","phase":"NA","title":"Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-01-21","conditions":"Shoulder Surgery, Obesity","enrollment":68},{"nctId":"NCT06616584","phase":"PHASE2, PHASE3","title":"Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2025-05-22","conditions":"Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":378},{"nctId":"NCT07345819","phase":"NA","title":"Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis","status":"NOT_YET_RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2026-04-01","conditions":"Orbital Cellulitis","enrollment":30},{"nctId":"NCT02813135","phase":"PHASE1, PHASE2","title":"European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2016-08-03","conditions":"Pediatric Cancer","enrollment":472},{"nctId":"NCT07343128","phase":"PHASE2, PHASE3","title":"Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia","status":"COMPLETED","sponsor":"Sanliurfa Education and Research Hospital","startDate":"2025-06-01","conditions":"Fibromyalgia","enrollment":68},{"nctId":"NCT01562405","phase":"PHASE1","title":"Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2012-05","conditions":"Multiple Myeloma","enrollment":33},{"nctId":"NCT07077850","phase":"NA","title":"Effect of IV Dexamethasone on Post-op Urinary Retention After Spinal Anesthesia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Al-Quds University","startDate":"2025-08-20","conditions":"Post Operative Urinary Retention, Spinal Aneshtesia","enrollment":1084},{"nctId":"NCT02343042","phase":"PHASE1, PHASE2","title":"Selinexor and Backbone Treatments of Multiple Myeloma Patients","status":"RECRUITING","sponsor":"Karyopharm Therapeutics Inc","startDate":"2015-10","conditions":"Multiple Myeloma","enrollment":300},{"nctId":"NCT03117751","phase":"PHASE2, PHASE3","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-03-29","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma","enrollment":790},{"nctId":"NCT05977998","phase":"PHASE2","title":"A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-09-08","conditions":"Gastric Adenocarcinoma, Carcinomatosis","enrollment":30},{"nctId":"NCT07227584","phase":"PHASE2","title":"ALL Backbone in AYAs","status":"NOT_YET_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2026-04","conditions":"Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)","enrollment":67},{"nctId":"NCT03132454","phase":"PHASE1","title":"Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-07-25","conditions":"Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":32},{"nctId":"NCT04537026","phase":"PHASE1, PHASE2","title":"Sterile Amniotic Fluid Filtrate Epidural Injection.","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-06-16","conditions":"Lumbar Spinal Stenosis","enrollment":61},{"nctId":"NCT05887765","phase":"PHASE4","title":"Effect of Systematic Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2023-10-17","conditions":"Ankle Disease, Foot Deformities, Foot Diseases","enrollment":90},{"nctId":"NCT07085728","phase":"PHASE2","title":"Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure","status":"NOT_YET_RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2025-08-11","conditions":"Myeloma Multiple","enrollment":74},{"nctId":"NCT07134075","phase":"PHASE2","title":"Intracochlear Injection of Glucocorticoid","status":"NOT_YET_RECRUITING","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2025-08-25","conditions":"Sudden Sensorineural Hearing Loss (SSNHL)","enrollment":150},{"nctId":"NCT07109258","phase":"EARLY_PHASE1","title":"Effect of Dexamethasone on Labour Induction in Term Pregnancies","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-05-01","conditions":"Labor Induction","enrollment":150},{"nctId":"NCT04432012","phase":"PHASE4","title":"A Study to Compare Different Ways of Steroid Administration After Total Knee Implantation","status":"RECRUITING","sponsor":"Christian Candrian","startDate":"2020-07-01","conditions":"Total Knee Replacement","enrollment":159},{"nctId":"NCT05451771","phase":"PHASE1, PHASE2","title":"Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis","status":"RECRUITING","sponsor":"Rajshekhar Chakraborty, MD","startDate":"2022-10-26","conditions":"AL Amyloidosis","enrollment":53},{"nctId":"NCT05546359","phase":"PHASE2, PHASE3","title":"Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients","status":"COMPLETED","sponsor":"Acacia Pharma Ltd","startDate":"2024-01-18","conditions":"Nausea and Vomiting, Postoperative","enrollment":453},{"nctId":"NCT06886230","phase":"PHASE4","title":"Ondansetron vs. Dexamethasone for Postoperative Nausea","status":"COMPLETED","sponsor":"Hafiz Muhammad Hamza","startDate":"2025-03-20","conditions":"Postoperative Nausea and Vomiting (PONV)","enrollment":105},{"nctId":"NCT05739682","phase":"NA","title":"Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Dental Pulp Necrosis","enrollment":28},{"nctId":"NCT06133712","phase":"NA","title":"Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-11-01","conditions":"Carpal Tunnel, Dexmedetomidine, Ozone","enrollment":135},{"nctId":"NCT05096663","phase":"PHASE2, PHASE3","title":"Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2022-03-15","conditions":"Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8","enrollment":82},{"nctId":"NCT05279092","phase":"PHASE2","title":"Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-09-08","conditions":"Total Knee Replacement, Knee Arthroplasty","enrollment":250},{"nctId":"NCT06330519","phase":"PHASE4","title":"Enhancing Anaesthetic Success in Mandibular Molars With Symptomatic Irreversible Pulpitis: A Comparative Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-02-01","conditions":"Pulpitis - Irreversible","enrollment":188},{"nctId":"NCT06953635","phase":"NA","title":"Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair","status":"NOT_YET_RECRUITING","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-06-01","conditions":"Hernia, Ventral, Pain Management","enrollment":70},{"nctId":"NCT06953440","phase":"PHASE4","title":"The Effect of Dexamethasone Submucosal Injection After Surgical Extraction of Lower Impacted Third Molars on Trismus and Edema","status":"RECRUITING","sponsor":"King Abdulaziz University","startDate":"2024-02-01","conditions":"Swelling/ Edema, Trismus","enrollment":66},{"nctId":"NCT06951087","phase":"PHASE3","title":"Intravitreal and Intracameral DEX in NPDR","status":"ENROLLING_BY_INVITATION","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-31","conditions":"Non-Proliferative Diabetic Retinopathy","enrollment":80},{"nctId":"NCT04747912","phase":"PHASE2","title":"Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-03-02","conditions":"Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT06846255","phase":"PHASE4","title":"Comparing DCP and DAP for Pemphigus Vulgaris","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2021-06-15","conditions":"Pemphigus Vulgaris","enrollment":66},{"nctId":"NCT06806410","phase":"PHASE4","title":"The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Luke's Hospital, Pennsylvania","startDate":"2023-05-01","conditions":"Hand Surgery, Wrist Surgery, Elbow Surgery","enrollment":120},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT04445337","phase":"PHASE1","title":"Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2020-11-15","conditions":"COVID 19, ARDS","enrollment":1},{"nctId":"NCT03754049","phase":"PHASE2","title":"A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Taiwan Liposome Company","startDate":"2019-01-21","conditions":"Osteoarthritis of the Knee","enrollment":102},{"nctId":"NCT04123561","phase":"PHASE3","title":"Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain","status":"COMPLETED","sponsor":"Taiwan Liposome Company","startDate":"2019-11-26","conditions":"Osteoarthritis of the Knee","enrollment":504},{"nctId":"NCT02375555","phase":"PHASE2","title":"Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2015-05-07","conditions":"Multiple Myeloma","enrollment":40},{"nctId":"NCT03859024","phase":"PHASE4","title":"Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-03-22","conditions":"Pain, Postoperative, Urethral Stricture","enrollment":48},{"nctId":"NCT03000634","phase":"PHASE2","title":"2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy","status":"WITHDRAWN","sponsor":"University of Arkansas","startDate":"2017-04-01","conditions":"Multiple Myeloma","enrollment":""},{"nctId":"NCT04392999","phase":"PHASE2, PHASE3","title":"Intra-articular Corticosteroid Injections to Platelet Rich Plasma (PRP) for Cervical Facetogenic Pain","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2021-02-01","conditions":"Cervical Pain","enrollment":55},{"nctId":"NCT05303311","phase":"PHASE4","title":"Intrathecal Pethidine Plus Dexamethasone for Distal Lower Orthopedic Surgeries","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-01-15","conditions":"Postoperative Pain","enrollment":46},{"nctId":"NCT02654990","phase":"PHASE2","title":"Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma","status":"COMPLETED","sponsor":"pharmaand GmbH","startDate":"2016-04-27","conditions":"Multiple Myeloma","enrollment":248},{"nctId":"NCT03166761","phase":"PHASE4","title":"Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-09-14","conditions":"Sacro-Iliac Spondylosis","enrollment":41},{"nctId":"NCT03942601","phase":"PHASE2","title":"Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization","status":"TERMINATED","sponsor":"Mercator MedSystems, Inc.","startDate":"2019-10-01","conditions":"Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05480111","phase":"PHASE4","title":"The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-09-07","conditions":"Pain, Postoperative","enrollment":76},{"nctId":"NCT04544683","phase":"PHASE4","title":"Effectiveness of Cervical Transforaminal Epidural Steroid Injection","status":"COMPLETED","sponsor":"University of Utah","startDate":"2018-10-23","conditions":"Cervical Radiculopathy, Cervical Spondylosis, Disk, Herniated","enrollment":33},{"nctId":"NCT06090500","phase":"NA","title":"Effect of Submucosal Cryotherapy on Postoperative Endodontic Pain","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-03-20","conditions":"Post-endodontic Pain","enrollment":52},{"nctId":"NCT03332316","phase":"PHASE4","title":"Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2017-11-02","conditions":"Postoperative Pain, Nerve Block","enrollment":84},{"nctId":"NCT02206425","phase":"PHASE1, PHASE2","title":"Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients","status":"COMPLETED","sponsor":"Oncotherapeutics","startDate":"2014-09","conditions":"Multiple Myeloma","enrollment":45},{"nctId":"NCT05887778","phase":"PHASE4","title":"Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery","status":"UNKNOWN","sponsor":"Poznan University of Medical Sciences","startDate":"2023-09-18","conditions":"Wrist Disease, Hand Injuries and Disorders","enrollment":90},{"nctId":"NCT02192827","phase":"PHASE3","title":"Use of Dexamethasone in Pediatric Asthma Exacerbations","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2015-04","conditions":"Asthma","enrollment":318},{"nctId":"NCT05647408","phase":"NA","title":"Evaluation of the Bioavailability of Dexamethasone in Healthy Subjects","status":"COMPLETED","sponsor":"Universidad Nacional Autonoma de Mexico","startDate":"2021-11-05","conditions":"Dexamethasone Administration, Intranasal Administration, Inflammation","enrollment":8},{"nctId":"NCT03382821","phase":"PHASE4","title":"Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach","status":"COMPLETED","sponsor":"University of Utah","startDate":"2017-09-15","conditions":"Cervical Radiculopathy","enrollment":120},{"nctId":"NCT03349281","phase":"PHASE1","title":"Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL","status":"COMPLETED","sponsor":"Julio Barredo, MD","startDate":"2019-03-25","conditions":"Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia","enrollment":6},{"nctId":"NCT01319981","phase":"PHASE2","title":"Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-03-05","conditions":"Leukemia","enrollment":31},{"nctId":"NCT03977454","phase":"PHASE2","title":"Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Yale University","startDate":"2019-11-11","conditions":"Hip Arthropathy","enrollment":192},{"nctId":"NCT04640168","phase":"PHASE3","title":"Adaptive COVID-19 Treatment Trial 4 (ACTT-4)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-12-02","conditions":"COVID-19","enrollment":1010},{"nctId":"NCT05271539","phase":"PHASE3","title":"Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-07-01","conditions":"Diabetic Macular Edema","enrollment":42},{"nctId":"NCT04337073","phase":"EARLY_PHASE1","title":"The Effect of Propofol on Dexamethasone-induced Perineal Pruritus","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2020-09-01","conditions":"Pruritus","enrollment":40},{"nctId":"NCT04326738","phase":"EARLY_PHASE1","title":"The Effect of Midazolam on Dexamethasone-induced Perineal Pruritus","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2020-01-16","conditions":"Pruritus","enrollment":90},{"nctId":"NCT02740127","phase":"PHASE3","title":"Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-06","conditions":"Malignant Neoplasms of Male Genital Organs","enrollment":52},{"nctId":"NCT03339284","phase":"PHASE4","title":"QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery","status":"UNKNOWN","sponsor":"Tampere University Hospital","startDate":"2017-12-04","conditions":"Postoperative Pain, Chronic Pain Post-Proceduraal, Nausea and Vomiting, Postoperative","enrollment":90},{"nctId":"NCT00299182","phase":"PHASE1, PHASE2","title":"Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-03","conditions":"Lymphoma","enrollment":50},{"nctId":"NCT01847001","phase":"PHASE2","title":"Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy","status":"COMPLETED","sponsor":"Columbia University","startDate":"2012-10","conditions":"Locally Advanced Malignant Neoplasm, Breast Cancer","enrollment":10},{"nctId":"NCT02732015","phase":"PHASE2","title":"Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-10-12","conditions":"Locally Advanced Sarcoma","enrollment":37},{"nctId":"NCT03200600","phase":"PHASE4","title":"Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery","status":"TERMINATED","sponsor":"Peking University First Hospital","startDate":"2017-08-02","conditions":"Carcinoma, Non-Small-Cell Lung, Surgery--Complications, Dexamethasone","enrollment":126},{"nctId":"NCT00103285","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-04-11","conditions":"Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":5377},{"nctId":"NCT02991339","phase":"PHASE2, PHASE3","title":"The Effects of Dexamethasone Administration on Jaundice Following Liver Resection","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2016-06","conditions":"Liver Dysfunction, Hepatectomy, Bilirubinaemia","enrollment":76},{"nctId":"NCT00075725","phase":"PHASE3","title":"Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-12-29","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":3154},{"nctId":"NCT02545907","phase":"PHASE1, PHASE2","title":"A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis","status":"COMPLETED","sponsor":"University College, London","startDate":"2017-09-14","conditions":"Amyloidosis","enrollment":10},{"nctId":"NCT03979664","phase":"EARLY_PHASE1","title":"Iontophoresis in Psoriasis","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2021-03","conditions":"Psoriasis, Psoriasis Vulgaris, Skin Diseases","enrollment":""},{"nctId":"NCT00773838","phase":"PHASE2","title":"Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-12-01","conditions":"Relapsed or Refractory Multiple Myeloma","enrollment":143},{"nctId":"NCT00439296","phase":"PHASE1, PHASE2","title":"ABT-751 With Chemotherapy for Relapsed Pediatric ALL","status":"TERMINATED","sponsor":"Therapeutic Advances in Childhood Leukemia Consortium","startDate":"2006-05-22","conditions":"Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia","enrollment":9},{"nctId":"NCT00671658","phase":"PHASE2","title":"Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-11","conditions":"Leukemia, Acute Lymphoblastic Leukemia","enrollment":220},{"nctId":"NCT04267913","phase":"PHASE2","title":"Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)","status":"WITHDRAWN","sponsor":"SWOG Cancer Research Network","startDate":"2020-09-05","conditions":"Lung Squamous Cell Carcinoma, Recurrent Lung Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":""},{"nctId":"NCT03028012","phase":"PHASE4","title":"TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone","status":"TERMINATED","sponsor":"University of Utah","startDate":"2017-05-02","conditions":"Myofascial Pain","enrollment":10},{"nctId":"NCT01155583","phase":"PHASE1, PHASE2","title":"Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2010-06","conditions":"Refractory Multiple Myeloma","enrollment":45},{"nctId":"NCT02266433","phase":"PHASE3","title":"Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow","enrollment":245},{"nctId":"NCT04603729","phase":"PHASE3","title":"Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease","status":"COMPLETED","sponsor":"Fatima Memorial Hospital","startDate":"2020-05-30","conditions":"Covid 19 Disease","enrollment":100},{"nctId":"NCT04593706","phase":"NA","title":"Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-11-01","conditions":"Keloid, Hypertrophic Scar, Scars","enrollment":40},{"nctId":"NCT02322242","phase":"PHASE4","title":"The Effects of Dexamethasone on Low Dose Interscalene Brachial Plexus Block","status":"COMPLETED","sponsor":"Dr. Stephen Choi","startDate":"2015-01","conditions":"Shoulder Surgery, Nerve Block","enrollment":182},{"nctId":"NCT03668860","phase":"PHASE1","title":"India Dexamethasone and Betamethasone","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-09-20","conditions":"Preterm Birth, Antenatal Corticosteroids","enrollment":48},{"nctId":"NCT00903968","phase":"PHASE1, PHASE2","title":"Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2009-06-01","conditions":"Multiple Myeloma","enrollment":58},{"nctId":"NCT03040011","phase":"PHASE1, PHASE2","title":"Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery","status":"COMPLETED","sponsor":"Lauren Giugale, MD","startDate":"2017-06-01","conditions":"Pelvic Organ Prolapse, Surgery, Postoperative Pain","enrollment":79},{"nctId":"NCT02479555","phase":"PHASE2","title":"Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization","status":"UNKNOWN","sponsor":"Mercator MedSystems, Inc.","startDate":"2016-01","conditions":"Chronic Limb Ischemia","enrollment":120},{"nctId":"NCT02479620","phase":"PHASE2","title":"Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization","status":"UNKNOWN","sponsor":"Mercator MedSystems, Inc.","startDate":"2016-06","conditions":"Chronic Limb Ischemia","enrollment":120},{"nctId":"NCT00440726","phase":"PHASE1, PHASE2","title":"Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","sponsor":"Therapeutic Advances in Childhood Leukemia Consortium","startDate":"2006-08-04","conditions":"Acute Lymphoblastic Leukemia","enrollment":31}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Decadron Phosphate, Injectable","genericName":"Decadron Phosphate, Injectable","companyName":"Hospital for Special Surgery, New York","companyId":"hospital-for-special-surgery-new-york","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone phosphate is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm. Used for Inflammatory and allergic disorders, Rheumatoid arthritis and other autoimmune conditions, Cerebral edema.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}